Target Price | $76.50 |
Price | $69.14 |
Potential | 10.65% |
Number of Estimates | 27 |
27 Analysts have issued a price target Microchip Technology 2026 . The average Microchip Technology target price is $76.50. This is 10.65% higher than the current stock price. The highest price target is $94.50 36.68% , the lowest is $57.57 16.73% . | |
A rating was issued by 32 analysts: 24 Analysts recommend Microchip Technology to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Microchip Technology stock has an average upside potential 2026 of 10.65% . Most analysts recommend the Microchip Technology stock at Purchase. |
28 Analysts have issued a sales forecast Microchip Technology 2026 . The average Microchip Technology sales estimate is $4.7b . This is 7.01% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.1b 16.89% , the lowest is $4.3b 2.17% .
This results in the following potential growth metrics:
2025 | $4.4b | 42.35% |
---|---|---|
2026 | $4.7b | 7.01% |
2027 | $5.8b | 22.14% |
2028 | $6.7b | 16.83% |
2029 | $6.6b | 2.04% |
2030 | $7.1b | 8.00% |
14 Analysts have issued an Microchip Technology EBITDA forecast 2026. The average Microchip Technology EBITDA estimate is $1.7b . This is 94.14% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.1b 138.00% , the lowest is $1.2b 43.81% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $866m | 72.62% |
---|---|---|
2026 | $1.7b | 94.14% |
2027 | $2.4b | 42.93% |
2028 | $3.0b | 24.79% |
2029 | $2.9b | 3.10% |
2030 | $3.3b | 14.41% |
2025 | 19.68% | 52.51% |
---|---|---|
2026 | 35.71% | 81.42% |
2027 | 41.79% | 17.03% |
2028 | 44.64% | 6.82% |
2029 | 44.15% | 1.10% |
2030 | 46.77% | 5.93% |
28 Microchip Technology Analysts have issued a net profit forecast 2026. The average Microchip Technology net profit estimate is $769m . This is 15,788.57% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $984m 20,185.71% , the lowest is $649m 13,352.04% .
This results in the following potential growth metrics and future Net Margins:
2025 | $-2.7m | 100.14% |
---|---|---|
2026 | $769m | 28,571.85% |
2027 | $1.4b | 84.97% |
2028 | $1.7b | 22.82% |
2029 | $2.3b | 29.31% |
2030 | $2.7b | 18.49% |
2025 | -0.06% | 100.25% |
---|---|---|
2026 | 16.32% | 26,705.23% |
2027 | 24.72% | 51.47% |
2028 | 25.99% | 5.14% |
2029 | 34.30% | 31.97% |
2030 | 37.63% | 9.71% |
28 Analysts have issued a Microchip Technology forecast for earnings per share. The average Microchip Technology EPS is $1.43 . This is 14,400.00% higher than earnings per share in the financial year 2025. The highest EPS forecast is $1.83 18,400.00% , the lowest is $1.21 12,200.00% .
This results in the following potential growth metrics and future valuations:
2025 | $-0.01 | 100.29% |
---|---|---|
2026 | $1.43 | 14,400.00% |
2027 | $2.64 | 84.62% |
2028 | $3.24 | 22.73% |
2029 | $4.19 | 29.32% |
2030 | $4.97 | 18.62% |
Current | -6,610.00 | 20,702.62% |
---|---|---|
2026 | 46.32 | 100.70% |
2027 | 25.04 | 45.94% |
2028 | 20.39 | 18.57% |
2029 | 15.77 | 22.66% |
2030 | 13.31 | 15.60% |
Based on analysts' sales estimates for 2026, the Microchip Technology stock is valued at an EV/Sales of 8.61 and an P/S ratio of 7.57 .
This results in the following potential growth metrics and future valuations:
Current | 9.21 | 23.29% |
---|---|---|
2026 | 8.61 | 6.56% |
2027 | 7.05 | 18.13% |
2028 | 6.03 | 14.40% |
2029 | 6.16 | 2.08% |
2030 | 5.70 | 7.41% |
Current | 8.10 | 23.07% |
---|---|---|
2026 | 7.57 | 6.55% |
2027 | 6.20 | 18.13% |
2028 | 5.31 | 14.40% |
2029 | 5.42 | 2.08% |
2030 | 5.02 | 7.41% |
Microchip Technology...
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Aug 08 2025 |
Raymond James |
Strong Buy
➜
Strong Buy
|
Unchanged | Aug 08 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Aug 08 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Jul 22 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Jul 18 2025 |
Goldman Sachs |
➜
Buy
|
Initiated | Jul 10 2025 |
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Jul 08 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Aug 08 2025 |
Unchanged
Raymond James:
Strong Buy
➜
Strong Buy
|
Aug 08 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Aug 08 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Jul 22 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Jul 18 2025 |
Initiated
Goldman Sachs:
➜
Buy
|
Jul 10 2025 |
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Jul 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.